PARP Inhibitor Toxicity Management

preview_player
Показать описание
Panelists discuss how to manage PARP inhibitor toxicities, including gastrointestinal and hematologic adverse events and fatigue.
  1. OncLive
  2. cancer
  3. oncology
Рекомендации по теме
PARP Inhibitor Toxicity 0:07:14

PARP Inhibitor Toxicity Management

Managing PARP Inhibitor 0:03:05

Managing PARP Inhibitor Toxicities in Ovarian Cancer

PARP Inhibitor Side 0:06:35

PARP Inhibitor Side Effect Management in Ovarian Cancer

Management of PARP 0:05:38

Management of PARP Inhibitor AEs in Ovarian Cancer

PARP Inhibitor Costs 0:01:56

PARP Inhibitor Costs Give Patients With Ovarian Cancer Financial Toxicity

PARP Inhibitors: Which 0:09:17

PARP Inhibitors: Which One Should We Use?

Dr. Matulonis on 0:02:30

Dr. Matulonis on Toxicities With PARP Inhibitors in Ovarian Cancer

PARP Inhibitors for 0:34:17

PARP Inhibitors for the Treatment of Ovarian Cancer - Gottfried Konecny, MD | UCLAMDChat

Advances in the 0:36:05

Advances in the Diagnosis, Assessment, and Therapeutic Management of BTC

PARP Inhibitor Therapy 0:50:21

PARP Inhibitor Therapy for Ovarian Cancer: Practical Prescribing and Medication Management

Role of PARP 0:16:22

Role of PARP Inhibitors in Prostate Cancer

Toxicities Associated with 0:02:31

Toxicities Associated with PARP Inhibitors in Ovarian Cancer

Toxicities Associated With 0:02:15

Toxicities Associated With Rucaparib for the Treatment of Ovarian Cancer

Dr. O'Malley on 0:01:11

Dr. O'Malley on Toxicity Profiles of PARP Inhibitors in Ovarian Cancer

PARP Inhibitors in 0:08:03

PARP Inhibitors in Ovarian Cancer: Safety Profile

What to Expect 0:01:29

What to Expect When Going on a PARP Inhibitor for Ovarian Cancer

PARP Inhibitor Combination 0:35:38

PARP Inhibitor Combination Regimens for Prostate Cancer Management

Personalizing Advanced Ovarian 0:57:11

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel Approaches

The Advanced Ovarian 1:29:06

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP Inhibitors

Difference Among PARP 0:06:39

Difference Among PARP Inhibitors for Ovarian Cancer

Testing for BRCA 0:07:04

Testing for BRCA Germline Mutations in the Clinic and the Mechanism of Action of PARP Inhibitors

Karen Lu, MD, 0:02:45

Karen Lu, MD, discusses how PARP inhibitors have changed the management of advanced ovarian cancer

PARP inhibitors in 0:59:14

PARP inhibitors in ovarian cancer: Clinical updates from SGO 2023

Managing Patients Treated 0:04:20

Managing Patients Treated With PARP Inhibitors